Brian Gallagher - Profile and Investment Details

Investor Profile

Brian Gallagher is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin, Syntaxin, CRISPR Therapeutics, Attenua, River Vision Development, Broncus Technologies, Slate Bio, Jasper Therapeutics, Synosia Therapeutics, X4 Pharmaceuticals, Constellation Pharmaceuticals, A MorphoSys Company, CalciMedicaKspine, Zogenix, Princeps Therapeutics, Springleaf Therapeutics, PrimeraDx (Primera Biosystems), Sirtris Pharmaceuticals, Scorpion Therapeutics, Avila Therapeutics, Personalis, MD On-Line, GenSight Biologics, Biogene Therapeutics Inc., Dicerna Pharmaceuticals, Cumulus Oncology, Verona Pharma, Micromet, Dicerna Pharmaceuticals, Inc., Proteon Therapeutics, Prosensa, Stanmore Implants Worldwide, GTx, Median Technologies, University of Michigan, Valeritas, Soleno Therapeutics, Zenon Biotech, Wilson Therapeutics, Chroma Therapeutics, Avillion, Hydra Biosciences, Nimbus Therapeutics, Michigan Biomedical Venture Fund, Algeta, Sientra, Intellikine, Chiasma, Gynesonics, Reneo Pharmaceuticals, Vera Therapeutics, Portola Pharmaceuticals, River Vision Development Corp., Nouscom, Vaxcyte, Lombard Medical plc, Labcyte, Pathwork Diagnostics, Senseonics, Translate Bio, A Sanofi Company, Novexel, Clovis Oncology, Atsena Therapeutics, Navitor Pharmaceuticals, Cytos, Q32 Bio Inc., Spero Therapeutics, VirionHealth, Phathom Pharmaceuticals, Constellation Pharmaceuticals, Fovea Pharmaceuticals, Venatorx Pharmaceuticals, IS Pharma, Stealth AI Startup, Effector Therapeutics, Sonitus Medical, Paratek Pharmaceuticals, Q32 Bio, GammaDelta Therapeutics, Tizona Therapeutics, Oxagen, SFJ Pharmaceuticals, Avedro, IFM Therapeutics, Alantos Pharmaceuticals Inc., Virion Biotherapeutics, Realm Therapeutics, eFFECTOR Therapeutics, Inc., Pixium Vision, . Over time, Brian Gallagher has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Brian Gallagher is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Life Science, Engineering, Finance, Biotechnology, Neuroscience, Clinical Trials, Medical, B2B, Therapeutics, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Brian Gallagher, as their portfolio suggests a familiarity and interest in this area.

Understanding Brian Gallagher’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.